NasdaqGS:BRKRLife Sciences
Is Bruker (BRKR) Quietly Repositioning Its Portfolio Around Automation-Led Life Science Workflows?
Earlier this week, Bruker showcased new analytical instruments at the Analytica 2026 conference, including the iNTApharma system for cell and gene therapy, an expanded Fourier 80 Automation Suite for chemistry labs, and the TITAN handheld analyzer for industrial elemental analysis.
The breadth of these launches underlines Bruker’s push to serve high-growth areas across biopharma, academic research, and industrial testing with more automated, application-focused tools.
Next, we’ll examine how...